Patents Assigned to Regenall Limited
  • Publication number: 20230338305
    Abstract: Vitamin A, and compositions, combined preparations, and multiple-dose formulations comprising vitamin A, for use in the treatment of acute and chronic traumatic brain injury are described, as well as methods of treatment of such injury using vitamin A, or the compositions, combined preparations, or multiple-dose formulations.
    Type: Application
    Filed: May 6, 2021
    Publication date: October 26, 2023
    Applicant: REGENALL LIMITED
    Inventor: Mohamed Hamza NOORDEEN
  • Publication number: 20230157975
    Abstract: Vitamin A and compositions comprising vitamin A, for use in the treatment of pulmonary fibrosis, including pulmonary fibrosis caused by respiratory infection, are described. Methods of treatment of pulmonary fibrosis using vitamin A and compositions are also described.
    Type: Application
    Filed: April 20, 2021
    Publication date: May 25, 2023
    Applicant: REGENALL LIMITED
    Inventor: Mohamed Hamza NOORDEEN
  • Patent number: 11551724
    Abstract: A system for instant assembly of video clips through user's interactive performance, comprising a device operated by a user, wherein the device comprises: user interface means configured for input and output interaction with the user; a processing unit and a memory configured for the creation of a new video assembled appending a plurality of video clip segments extracted from a plurality of video clips; and an I/O unit configured for access to the plurality of video clips; the user interface means are configured to detect a sequence of manual assembling commands, and to display the plurality of video clip segments, the display order of the video segments being defined by the sequence of manual concatenation commands; the processing unit and the memory are configured to record the appending process of the video segments extracted from a plurality of video clips.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: January 10, 2023
    Assignee: REGENALL LIMITED
    Inventor: Mario Amura
  • Publication number: 20220016049
    Abstract: Compounds, compositions, combined preparations, and multiple-dose formulations, for use in the treatment of tissue damage or injury, in particular, for example, spinal cord injury and tendon injury, are described. Methods of treatment of tissue damage or injury using the compounds, compositions, combined preparations, or multiple-dose formulations, are also described. Vitamin A, and optionally one or more regenerative cells, is used to inhibit scar tissue formation in a subject, which is a necessary prerequisite for successful tissue regeneration following tissue damage or injury.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 20, 2022
    Applicant: Regenall Limited
    Inventor: Mohamed Hamza NOORDEEN